By continuing to browse the site, you are agree on the use of cookies to track the number of visits.To know more about cookies policy:click here
02 May 2019

China’s equity market is opening-up: What does it mean for you?

In our view, China is simply too big to ignore and too great an investment opportunity to miss, so it could be time for investors to consider adding a separate, specific allocation to their portfolio. But the market is notoriously hard to navigate. Chan Samadder has the solution.  

China’s lengthy transition towards a consumer-led economy and the likelihood of higher current account deficits demands greater capital inflows from foreign investors. The People’s Republic has made significant progress in opening-up its economy and liberalising its markets over the past two decades, but more is needed. The Chinese equity market remains vastly underrepresented in global indices despite its size. About two thirds of the equity value in Chinese companies is still not available for trading, which contrasts sharply with the US stock market. Capital restrictions and state ownership remain the two major hurdles for the freer flow of capital. 

Tackling some tricky trade-offs

Mainland companies have had no choice but to navigate a variety of trade-offs in determining where they should legally incorporate and where they should publicly list their equity. As a result, Chinese companies currently trade in five different currencies on seven exchanges. 

understanding chinese

Many Chinese companies incorporate or list their shares overseas for a number of reasons (e.g. lower tax rates, favourable regulation…). While H shares have been strongly represented in Chinese stock indices, they are heavily weighted towards financials and are not fully representative of China’s public markets. The Chinese government remains a major shareholder and large portions of companies’ stock are still not eligible for trading. 

A more retail market

The Chinese equity markets differ greatly from those elsewhere. Retail investors own most of the listed shares on the mainland so there is a much higher turnover in portfolios than we’d see among longer-term, institutional investors. Furthermore, equities only represent a small portion of their wealth. Households are mainly invested in property, wealth management products, and bank deposits. Stock financing is also small for Chinese corporates as opposed to bank loans and retained earnings. As a result, Chinese corporates are less sensitive to market gyrations than their developed world peers.

China’s Shanghai Composite Index meanwhile is dominated by state-owned companies – each of the top ten valued companies are SOEs for example. The Communist Party floats only a small percentage of a company’s equity on the stock exchange while keeping control of the rest. Therefore, a core part of valuations cannot be truly factored in to the company’s stock price. Share prices may well be a reflection of market liquidity and demand rather than corporate value.

Opening-up to foreign investors

In an early effort to open the local market to foreign institutional investors, China introduced quota programmes in 2002 (QFII) and in 2011 (RQFII). These programmes eventually allowed asset managers to list international ETFs with exposure to mainland China securities. Then, in 2014, the authorities introduced the Shanghai Hong Kong Stock Connect, giving investors the ability to buy and sell Shanghai-listed stocks without prior approval from China’s regulatory bodies via a brokerage account in Hong Kong. The Shenzhen Hong Kong Stock Connect was launched a couple of years later. Finally, MSCI started introducing A shares into their Global Standard Indexes starting in June 2018.

Staying with MSCI, the bellwether EM index provider recently announced it will quadruple the weight of securities from the MSCI China A Inclusion Index in their Global Standard Indexes from 5% to 20% in three tranches, starting at the end of May and concluding in November. On top of adding 253 large-cap China A shares, MSCI will expand its coverage to include 168 medium-sized corporates for the first time. The inclusion of 27 stocks from ChiNext is also a sign of further diversification in the future, with the addition of securities from growth sectors such as IT and healthcare. 

opening up to foreign investors

Source: MSCI, data as at 22 January 2019. All figures are approximate.

Eventually, full inclusion will lead to a total China exposure of 40% in the MSCI Emerging Markets Index.

msci emerging market

Source: MSCI, data as at 22 January 2019. All figures are approximate

For onshore exposure, our China A ETF is ahead of its time

By November, MSCI’s 3-step inclusion process will be complete. Large-cap China A shares will have reached a weighting of 20%, as will China A mid-caps.


That’s why we took the opportunity to switch the index of our physically replicated China A shares ETF from the MSCI China A Onshore Net Total Return Index to the new MSCI China A Net Total Return Index in March. We believe this index is the best reflection of how any future China A Shares index building block will look post November 2019.

Unlike the MSCI China A Inclusion Index – which is built to evolve sequentially in line with MSCI’s inclusion timeline – our index accounts for all of the inclusions immediately, so it should benefit from the inflows we expect to see into A shares in the lead up to November. Our ETF is also the first in the market to include the mid-cap A Shares and is, in our view, the most representative of the full China A opportunity set.

China A ETF

Source: Lyxor International Asset Management, April 2019. For illustrative purposes only. This is not a recommendation.


Find out more about how to invest in China

Why choose Lyxor’s Chinese ETFs

Lyxor’s Chinese ETFs

Source for all data unless otherwise indicated: Lyxor international Asset Management, Bloomberg, data as at 26/03/2019. *TER correct as of 01/05/2019.

Relevant products




Risk Warning​

This document is for the exclusive use of investors acting on their own account and categorised either as “Eligible Counterparties” or “Professional Clients” within the meaning of Markets in Financial Instruments Directive 2014/65/EU. These products comply with the UCITS Directive (2009/65/EC). Société Générale and Lyxor International Asset Management (LIAM) recommend that investors read carefully the “investment risks” section of the product’s documentation (prospectus and KIID). The prospectus and KIID are available free of charge on www.lyxoretf.com, and upon request to client-services-etf@lyxor.com.

Except for the United-Kingdom, where this communication is issued in the UK by Lyxor Asset Management UK LLP, which is authorized and regulated by the Financial Conduct Authority in the UK under Registration Number 435658, this communication is issued by Lyxor International Asset Management (LIAM), a French management company authorized by the Autorité des marchés financiers and placed under the regulations of the UCITS (2014/91/EU) and AIFM (2011/61/EU) Directives. Société Générale is a French credit institution (bank) authorised by the Autorité de contrôle prudentiel et de résolution (the French Prudential Control Authority).

The products mentioned are the object of market-making contracts, the purpose of which is to ensure the liquidity of the products on the London Stock Exchange, assuming normal market conditions and normally functioning computer systems. Units of a specific UCITS ETF managed by an asset manager and purchased on the secondary market cannot usually be sold directly back to the asset manager itself. Investors must buy and sell units on a secondary market with the assistance of an intermediary (e.g. a stockbroker) and may incur fees for doing so. In addition, investors may pay more than the current net asset value when buying units and may receive less than the current net asset value when selling them. Updated composition of the product’s investment portfolio is available on www.lyxoretf.com. In addition, the indicative net asset value is published on the Reuters and Bloomberg pages of the product, and might also be mentioned on the websites of the stock exchanges where the product is listed.

Prior to investing in the product, investors should seek independent financial, tax, accounting and legal advice. It is each investor’s responsibility to ascertain that it is authorised to subscribe, or invest into this product. This document is of a commercial nature and not of a regulatory nature. This material is of a commercial nature and not a regulatory nature. This document does not constitute an offer, or an invitation to make an offer, from Société Générale, Lyxor Asset Management (together with its affiliates, Lyxor AM) or any of their respective subsidiaries to purchase or sell the product referred to herein.

Research disclaimer

Lyxor International Asset Management (“LIAM”) or its employees may have or maintain business relationships with companies covered in its research reports. As a result, investors should be aware that LIAM and its employees may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. Please see appendix at the end of this report for the analyst(s) certification(s), important disclosures and disclaimers. Alternatively, visit our global research disclosure website www.lyxoretf.com/compliance.

Conflicts of interest 

This research contains the views, opinions and recommendations of Lyxor International Asset Management (“LIAM”) Cross Asset and ETF research analysts and/or strategists. To the extent that this research contains trade ideas based on macro views of economic market conditions or relative value, it may differ from the fundamental Cross Asset and ETF Research opinions and recommendations contained in Cross Asset and ETF Research sector or company research reports and from the views and opinions of other departments of LIAM and its affiliates. Lyxor Cross Asset and ETF research analysts and/or strategists routinely consult with LIAM sales and portfolio management personnel regarding market information including, but not limited to, pricing, spread levels and trading activity of ETFs tracking equity, fixed income and commodity indices. Trading desks may trade, or have traded, as principal on the basis of the research analyst(s) views and reports. Lyxor has mandatory research policies and procedures that are reasonably designed to (i) ensure that purported facts in research reports are based on reliable information and (ii) to prevent improper selective or tiered dissemination of research reports. In addition, research analysts receive compensation based, in part, on the quality and accuracy of their analysis, client feedback, competitive factors and LIAM’s total revenues including revenues from management fees and investment advisory fees and distribution fees.

Connect with us on linkedin